2. 

Smith, A.G., Nichols, J., Robertson, M., and Rathjen, P.D. (1992) Differentiation inhibiting activity (DIA/LIF) and mouse development. Dev. Biol. 151: 339-351. 全文

 3. 

Takahashi, K., Tanabe K., Ohnuki, M., Narita, M., Ichisaka T., Tomoda K. and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872. 全文

 4. 

Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., Slukvin, I.I., and Thomson, J.A. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.全文

 2.

Yoo J; La Y; Lee EJ; Choi J-J; Oh J; Thang NX; Hong K. ATP-Dependent chromatin remodeler CHD9 controls the proliferation of embryonic stem cells in a cell culture condition-dependent manner. Biology 9:428 (2020). 全文

 3.

Chung CY; Lo PHY; Lee KKH. Babam2 Regulates Cell Cycle Progression and Pluripotency in Mouse Embryonic Stem Cells as Revealed by Induced DNA Damage. Biomedicines 8:397 (2020).全文

 4.

Torzal F; Lau QY; Ibuki M; Kawai T; Horikawa M; Minami M; Horiguchi I; Nishikawa M; Sakai Y. High-density hiPSCs expansion supported by growth factors accumulation in a simple dialysis-culture platform. Research Square ://doi.org/10.21203/rs.3.rs-71643/v1(2020). 全文

 5.

Choi NY; Bang JS; Park YS; Lee M; Hwange HS; Ko K; Myung SC; Tapia N; Schöler HR; Kim GJ; Ko K. Generation of human androgenetic induced pluripotent stem cells. Sci Rep 10:3614 (2020).全文

 6.

Hu X; Wu Q; Zhang J; Chen X; Hartman A; Eastman A: Guo S. Reprogramming progressive cells display low CAG promoter activity. bioRxiv :https://doi.org/10.1101/2020.03.03.975664 (2020).全文

 7.

Parfenov VA; Mironov VA; Koudan EV; Nezhurina EK; Karalkin PA; Pereira FDAS; Petrov SV; Krokhmal KK; Tydemir R; Vakhrushev EV; Zobkov YV; Smirnov IV; Fedotov AY; Demirci U; Khesuani YD; Komlev VS. Fabrication of calcium phosphate 3D scaffolds for bone repair using magnetic levitational assembly. Sci Rep 10:4013 (2020).全文

 8.

Choi NY; Bang JS; Park YS; Lee M; Hwange HS; Ko K; Myung SC; Tapia N; Schöler HR; Kim GJ; Ko K. Generation of human androgenetic induced pluripotent stem cells. Sci Rep 10:3614 (2020). 全文

 9.

Ha M; Athirasala A; Tahayeri A; Menezes PP; Bertassoni LE. Micropatterned hydrogels and cell alignment enhance the odontogenic potential of stem cells from apical papilla in-vitro. Dental Materials in press:doi.org/10.1016/j.dental.2019.10.013 (2019).全文

10.

Hao Y; Fan X; Shi Y; ZXhang C; Sun E-E; Qin K; Qin W; Zhou W; Chen X. Next-generation unnatural monosaccharides reveal that ESRRB O-GlcNAcylation regulates pluripotency of mouse embryonic stem cells. Nature Commun 10:4065 (2019). 全文

11.

Ge N; Liu M; Krawczyz J; McInerney V; Galvin J; Shen S; O'Brien T; Prendiville T. Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-B). Stem Cell Res in press:https://doi.org/10.1016/j.scr.2019.101502 (2019).全文

12.

Mura M; Pisano F; Stefanelllo M; Cinevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Brink PA; Gnecchi M. Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population. Stem Cell Res in Press:https://doi.org/10.1016/j.scr.2019.101510 (2019). 全文

13.

Headley KM; Kedziora KM; Alejo A; Lai EZ-X; Purvis JE; Hathaway NA. Chemical screen for epigenetic barriers to single allele activation of Oct4. Stem Cell Res in Press:https://doi.org/10.1016/j.scr.2019.101470 (2019).全文

14.

Johari B; Asadi Z; Rismani E; Maghsood F; Rezaei ZS; Farahani S; Madanchi H; Kadivar M. Inhibition of transcription factor T‐cell‐factor 3 (TCF3) using oligodeoxynucleotide strategy increases embryonic stem cell stemness: The possible application in regenerative medicine. Cell Biol Intl in press:doi: 10.1002/cbin.11153 (2019). 全文

15.

Watanabe T; Yamazaki S; Yoneda N; Shinohara H; Tomioka I; Iiguchi T; Tagoto M; Ema M; Suemizu H; Kawai K; Sasaki E. Highly efficient induction of primate iPS cells by combining RNA transfection and chemical compounds. Genes to Cells in press:doi:10.1111/gtc.12702 (2019).全文

16.

Panina Y. Development of a new high-precision quantification methodology for gene expression analysis and its application in iPS cells. Doctoral Thesis, Osaka University : (2019).全文

17.

Soda M; Saitoh I; Murakami T; Inada E; Iwase Y; Noguchi H; Shibasaki S; Murosawa M; Sawami T; Terunuma M; Kubota N; Terao Y; Ohshima H; Hayasaki H; Sato M. Repeated human deciduous tooth-derived dental pulp cell reprogramming factor transfection yields multipotent intermediate cells with enhanced iPS cell formation capability. Sci Rep 9:1490 (2019). 全文

18.

Lin VJT; Zolekar A; Shi Y; Koneru B; Dimitrijevich S; Di Pasqua AJ; Wang C-Y. Potassium as a pluripotency-associated element identified through inorganic element profiling in human pluripotent stem cells. Sci Reports 7:5005 (2017). 全文

19.

Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MA; Zeng X. Derivation, characterization, and neural differentiation of integration-free induced pluripotent stem cell lines from Parkinson's disease patients carrying SNCA, LRRK2, PARK2, and GBA mutations. _PLoS ONE_ 11(5): e0154890\. doi:10.1371/journal.pone.0154890 (2016). 全文

20.

Borenstrom C; Simonsson S; Enochson L; BIgdeli N; Branstsing C; Ellerstrom C; Hyllner J; Lindahl A. Footprint-Free Human Induced Pluripotent Stem Cells From Articular Cartilage With Redifferentiation Capacity: A First Step Toward a Clinical-Grade Cell Source. Stem Cells Translat Med 3:433-447 (2014). 全文